Skip to main content

Peer Review reports

From: NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice

Original Submission
11 Jan 2023 Submitted Original manuscript
28 Jan 2023 Author responded Author comments - Abdolvahab Moradi
14 Apr 2023 Reviewed Reviewer Report
4 May 2023 Reviewed Reviewer Report
15 May 2023 Author responded Author comments - Abdolvahab Moradi
Resubmission - Version 2
28 Jan 2023 Submitted Manuscript version 2
16 May 2023 Author responded Author comments - Abdolvahab Moradi
Resubmission - Version 3
16 May 2023 Submitted Manuscript version 3
11 Jun 2023 Reviewed Reviewer Report - Amany A. Ghazy
12 Jun 2023 Reviewed Reviewer Report
23 Jul 2023 Author responded Author comments - Abdolvahab Moradi
Resubmission - Version 4
23 Jul 2023 Submitted Manuscript version 4
24 Jul 2023 Author responded Author comments - Abdolvahab Moradi
Resubmission - Version 5
24 Jul 2023 Submitted Manuscript version 5
25 Jul 2023 Author responded Author comments - Abdolvahab Moradi
Resubmission - Version 6
25 Jul 2023 Submitted Manuscript version 6
Publishing
31 Jul 2023 Editorially accepted
7 Aug 2023 Article published 10.1186/s13104-023-06445-5

You can find further information about peer review here.

Back to article page